Enoxaparin Sodium
Brand name: Enoxaparin Sodium
Rank #492 of 500 drugs by total cost
$14.2M
Total Cost
93,202
Total Claims
$14.2M
Total Cost
3,767
Prescribers
$152
Cost per Claim
28,348
Beneficiaries
94,515
30-Day Fills
$3,773
Avg Cost/Provider
25
Avg Claims/Provider
About Enoxaparin Sodium
Enoxaparin Sodium (sold as Enoxaparin Sodium) was prescribed 93,202 times by 3,767 Medicare Part D providers in 2023, costing the program $14.2M. At $152 per claim, this is a moderately priced medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 489 | Colesevelam Hcl (Colesevelam Hcl) | $14.3M | 50,268 |
| 490 | Bexarotene (Bexarotene) | $14.2M | 1,613 |
| 491 | Ozanimod Hydrochloride (Zeposia) | $14.2M | 1,535 |
| 492 | Enoxaparin Sodium (Enoxaparin Sodium) | $14.2M | 93,202 |
| 493 | Omadacycline Tosylate (Nuzyra) | $14.1M | 1,395 |
| 494 | Binimetinib (Mektovi) | $14.1M | 1,094 |
| 495 | Glecaprevir/Pibrentasvir (Mavyret) | $14.1M | 1,011 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology